The Gene Therapy Society of Singapore was set up in 2024 to provide a platform to bring together clinicians, researchers, industry and patients involved in genetic medicine and therapies. Rather than focusing on the scientific community only, the society is also bringing together individuals involved in translation, deployment, advocacy and outreach of gene therapy, so as to be a bridge between cutting edge research and real world impact.
Gene Therapy Society of Singapore seeks to:
Advance & promote the translation of genetic medicine and therapies;
Advocate for availability of genetic medicine to patients;
Enhance public understanding of genetic medicine and therapies.
We hope those of you working on or having an interest in genetic medicine can join us in this society and help shape the direction it moves in.
The Gene Therapy Society of Singapore (GTSS), in collaboration with Chapter of Genomic Medicine, Academy of Medicine, Singapore and supported by College of Clinician Scientists, will organise a series of webinars on cell and gene therapy in Cancer.
We are pleased to have Professor Toh Han Chong, Deputy CEO, National Cancer Centre Singapore (NCCS) and Senior Consultant, Division of Medical Oncology, NCCS, to share on ‘CAR-T for solid tumours: Highway to the promised land or a wrong turn?’
Date: 05 May 2025 (Monday)
Time: 12.30pm – 1.30pm
Refer to the publicity flyer as attached for more details.
Please register for the webinar.
Do ensure that you have entered the correct email address and check your junk/spam folder if you did not receive the webinar details after registration.
P.S. Remember to sign up for membership if you have yet to do so! This will ensure you will get the latest information on upcoming events!
The GTSS executive committee wishes all members an exciting and fulfilling 2025!
The GTSS came into being in late 2023 as an idea among friends to bring together like-minded scientists, clinicians and patient advocates under the same umbrella in the space of molecular therapies for genetic diseases.
Over good food and coffee, the idea to start a gene therapy interest group in Singapore took shape, and we were pleased to see that there was a common interest across various disciplines. As the goal was, and is, to bring together gene therapy specialists across Singapore, and to enhance knowledge of advancements and collaborations among our own network of Singaporean institutions, we formed the Gene Therapy Society of Singapore in 2024. The Society has been registered with the Registry of Societies (ROS) under MHA (UEN T24SS0034L). Our first Annual General Meeting was held on 8 July, 2024.
The vision of the Society (GTSS) is to be the thought-leader for advancement of genetic medicine and therapies in Singapore and Asia, to promote the translation of genetic therapies to clinical applications, and to advocate for genetic medicine to be available to those who need it. The Society’s mission is to organize and hold events, meetings, and symposia related to Gene Therapy, to be a platform for collaborations, combined research and grant application, to enhance public understanding of genetic medicine while upholding ethical and regulatory standards.
To this effect, we will be planning activities over the coming years to foster greater synergy and cohesion between the numerous gene therapy groups in Singapore. This year we will launch a webinar series for scientists and clinicians to learn about various disease-focused gene therapies and delivery platforms, as well as collaborative activites between GTSS and other Singapore institutions. Please refer to this website for updates on our planned activites.
We hope you will find our activities informative and engaging. Please join us on this journey by becoming a member (link here).
Citra Mattar
President, Gene Therapy Society Singapore
Membership benefits:
1. Attendance at Annual General Meetings
2. Attendance at GTSS conferences, webinars and other events at discounted rates
3. Invitation to networking events (academia and industry)
4. Participation at workshops at discounted rates
For archived posts, please click here.
President
Assoc Prof Citra Mattar
A clinician-scientist based at National University Hospital Department of Obstetrics and Gynaecology working on fetal gene therapy.
Vice President
Dr Koh Ai Ling
A clinician specializing in pediatric genetics based at the KK Women's and Children's Hospital
Secretary
Asst Prof Chin Hui-Lin
A Consultant with the Division of Genetics and Metabolism, Khoo Teck Puat – National University Children's Medical Institute, National University Hospital.
Treasurer
Asst Prof Gan Shu Uin
A Research Assistant Professor at the Yong Loo Lin School of Medicine - Surgery working on AAV-mediated gene therapy
Committee
Asst Prof Volker Patzel
A Senior Lecturer at the Department of Microbiology and Immunology at the Yong Loo Lin School of Medicine with an interest in RNA Technologies and Delivery
Committee
Dr Seow Yiqi
A Scientist working at the Genomic Institute of Singapore working on gene circuitry
Committee
Asst Prof Kaavya Narasimhalu
Dr Kaavya is a clinician scientist with a focus on Neurogenetics and precision medicine at the SingHealth Duke-NUS Genomic Medicine Centre
Committee
Asst Prof Saumya Jamuar
A Senior Consultant specializing in pediatrics genetics at the KK Woman's and Children's Hospital as well as the Deputy Director (Clinical) at SingHealth Duke-NUS Institute of Precision Medicine